It began in 2020 with a coordinated push to generate public backlash to lockdowns. The ultimate aim was restoring normalcy, ending a politically and economically inconvenient crisis. Over time, ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

Samsung Biologics originally established Samsung Bioepis as a joint venture with U.S. pharmaceutical company Biogen Inc. in ...

Having already worked with clinical trial sites in more than 14 states, CTAC will now take its work nationwide, the ...

Attorneys discuss ‘Loper Bright Enterprises v. Raimondo’ and its impact to medical patent cases. Many anticipated that Loper ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

The lyophilized injectable market is poised for growth due to increasing demand for biologics and specialty drugs, R&D activities, and global collaborations. Key opportunities include leveraging ...

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for certain ...

The award-winning scientist is solving health problems in the global south and inspiring other girls to follow suit ...

U.S. drugmaker Pfizer said it would license an experimental cancer treatment from China's 3SBio Inc , paying $1.25 billion ...

Investor call and webcast scheduled for today at 8:30 a.m. ET NEW YORK, May 19, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ...